0001415889-24-005093.txt : 20240223
0001415889-24-005093.hdr.sgml : 20240223
20240223173004
ACCESSION NUMBER: 0001415889-24-005093
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240206
FILED AS OF DATE: 20240223
DATE AS OF CHANGE: 20240223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horn David R.
CENTRAL INDEX KEY: 0001834217
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39747
FILM NUMBER: 24672781
MAIL ADDRESS:
STREET 1: 3800 BRIDGE PARKWAY
STREET 2: SUITE 102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seer, Inc.
CENTRAL INDEX KEY: 0001726445
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 821153150
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3800 BRIDGE PARKWAY, SUITE 102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 650-453-0000
MAIL ADDRESS:
STREET 1: 3800 BRIDGE PARKWAY, SUITE 102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: Seer Biosciences, Inc.
DATE OF NAME CHANGE: 20171226
4
1
form4-02232024_100257.xml
X0508
4
2024-02-06
0001726445
Seer, Inc.
SEER
0001834217
Horn David R.
C/O SEER, INC.
3800 BRIDGE PARKWAY, SUITE 102
REDWOOD CITY
CA
94065
false
true
false
false
PRESIDENT & CFO
0
Class A Common Stock
2024-02-06
4
A
0
165038
0
A
493195
D
Class A Common Stock
2024-02-22
4
S
0
12684
1.5787
D
480511
D
Employee Stock Option (right to buy)
1.77
2024-02-06
4
A
0
142557
0
A
2034-02-06
Class A Common Stock
142557
142557
D
Employee Stock Option (right to buy)
1.77
2024-02-06
4
A
0
140000
0
A
2034-02-06
Class A Common Stock
140000
140000
D
The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on February 15, 2025.
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of RSUs.
One-fourth of the shares subject to the option vest on February 6, 2025 and 1/48th of the shares vest monthly thereafter.
The option is subject to vesting requirements based upon achievement of specified performance-based criteria (the "Stock Price Hurdle") which requires that the Issuer achieve a stock price equal to or greater than 200% of the option exercise price during the period beginning on the grant date and ending on February 6, 2031 (the "Performance Period"). If the Stock Price Hurdle is achieved within the Performance Period, then one-fourth of the shares subject to the option vest on the date that achievement of the Stock Price Hurdle is certified and the remaining shares vest annually thereafter in three equal installments.
/s/ David Horn
2024-02-23